Target intelligence / Profile preview

ArfGAP with GTPase domain, ankyrin repeat and PH domain 12, pseudogene (AGAP12P)

Target: AGAP12P
Molecular classification: Other (Pseudogene)

Overview

AGAP12P (ArfGAP with GTPase domain, ankyrin repeat and PH domain 12, pseudogene) is a human pseudogene. Pseudogenes are genomic sequences similar to those of functional genes but are generally non-functional due to mutations, deletions, or truncations, and do not produce active proteins. There are no known biological, disease, or pharmacological roles for this gene, and it is not considered for therapeutic targeting.

Other names: bA164N7.2CTGLF12P

Beyond the preview

Go deeper on ArfGAP with GTPase domain, ankyrin repeat and PH domain 12, pseudogene (AGAP12P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArfGAP with GTPase domain, ankyrin repeat and PH domain 12, pseudogene (AGAP12P).

Explore the full profile